Oceanpine Capital

Xingchen New Energy develops new generation of ultra-high-performance all-vanadium flow energy storage system, fully covering electrolyte, stack and core R&D, manufacturing and production of components, energy storage systems and other products, and provide safer comprehensive energy storage solutions.

Blue Wave is a producer of Industrial IoT and Internet of Vehicles chips.

Renxin Technology is an automotive chip design company. It provides competitive chip and system solutions for the industry and follows the evolution and development of automotive EE architecture.

Kuixin Technology specializes in the development and supply of integrated circuits aimed at addressing challenges related to computing power scaling and high-speed interconnection. The company offers a range of products, including USB, PCIe, SATA, SerDes, MIPI, DDR, HDMI, DP, and HBM chipsets. These components are designed for various applications across multiple sectors, including data centers, artificial intelligence, consumer electronics, automotive, and the Internet of Things (IoT). By focusing on these areas, Kuixin contributes to enhancing the performance and connectivity of modern technological systems.

SIRUI is an intelligent technology company that concentrates on the growth of strategic emerging industries and key core technologies such as semiconductor equipment and new display. Their products include atomic layer deposition coating equipment and thin-film electroluminescence displays. Its overseas technology research and development center will gradually conduct research, development, and industrialization of ALD and EL technology. It provides mature and leading ALD coating solutions for global customers in industrial coating applications such as semiconductors and optoelectronics, and it aids in the development of related industries such as semiconductors.

Qinghai Lihao specializes in the research, development, production, and sales of crystalline silicon, particularly for use in semiconductor materials. The company is dedicated to mass production of high-purity crystalline silicon, which supports the renewable energy sector and meets the demands of clients in the semiconductor industry. By focusing on process technology, Qinghai Lihao aims to advance its capabilities in the new energy business while ensuring the availability of essential materials for various applications.

Enflame, also known as Suiyuan Technology, specializes in developing advanced neural network solutions for artificial intelligence applications. The company focuses on creating high-end deep learning chips designed specifically for cloud data centers, optimizing them for AI training platforms. These chips feature a proprietary architecture that delivers significant computational power while ensuring high energy efficiency and low costs. Additionally, they are programmable and compatible with mainstream machine learning frameworks, making them suitable for a wide range of AI training and optimization tasks.

Huachen Core Light is a semiconductor technology company that produces and manufactures optical communications and laser chips.

Aqronos specializes in advanced LiDAR technology designed for autonomous vehicles. The company develops innovative LiDAR sensors that enhance the vision capabilities of vehicles, transforming them into effective guardians on the road. By focusing on improving both autonomous driving and driver assistance systems, Aqronos aims to provide a safer driving experience for all users.

Shenzhen Shifeng offers industrial software, digital twin systems, and a simulation cloud service platform. The company serves marine engineering, aerospace, energy, electronic appliances, car traffic, and engineering manufacturing.

Clounix is a software startup specializing in high-performance network chips and solutions, particularly focusing on application-specific integrated circuits (ASICs) designed for cloud networking. The company is dedicated to enhancing cloud networking technology through the development of ASICs that facilitate high-speed packet switching. Clounix supports super-internet companies, medium and large enterprises, and network operators in building next-generation networks and data centers. By creating advanced hardware and tailored software that align with cloud-native ecosystems, Clounix plays a crucial role in the evolution of modern networking infrastructure, catering to the needs of global Internet manufacturers and businesses seeking to improve their network capabilities.

Liansu Technology is a software company that develops graphics rendering GPUs. It intends to focus on self-developed architecture and proprietary intellectual property rights to create domestically-made GPU chips that are benchmarked against international mainstreams, serve the domestic 200 billion rendering GPU all-round market, and realize high-performance graphics rendering on the device, cloud, and car/side. The company is helping to build the computing core, keeping up with the times, computing technology is oriented to the needs of the underlying core chips of the digital economy, leveraging self-developed architecture, in display acceleration, game e-sports, digital twins, metaverse, VR/AR, ultra-high-definition video, professional design, and other fields to provide partners with high-performance software and hardware solutions.

OrthoGuard Physicians is a comprehensive orthopedic medical service organization based in China, focusing on the treatment and diagnosis of various musculoskeletal conditions, including joint, spine, ankle, and trauma injuries. The company emphasizes efficient management and innovative operational models to enhance patient care, facilitating quicker healing and improved recovery experiences. In addition to direct medical services, OrthoGuard is involved in hospital management, rehabilitation services, and education and training initiatives. The organization also engages in supply chain management and the establishment of demonstration diagnosis and treatment centers, aiming to create a reputable and innovative medical group in the orthopedic field. Through these efforts, OrthoGuard seeks to leverage its extensive resources and expertise to advance orthopedic healthcare in China.

Erised Semiconductor is a circuit designer and manufacturer that provides users with display driver and power management chips. The applications can be found in radiofrequency applications, discrete devices, and other products.

MingMed is a Chinese pharmaceutical company focused on independent drug research and development, with a diverse product pipeline that includes ophthalmic drugs, small molecule immune drugs, and cell therapies utilizing gene editing. The company's offerings extend to recombinant protein botulinum toxin, tumor immune drugs, and immunotherapy for pets. MingMed is dedicated to producing innovative solutions across various fields, including ophthalmology, medical aesthetics, and veterinary medicine, with several of its promising drug candidates having reached the clinical stage. The company's commitment to developing First-in-Class innovative drugs positions it competitively in the global pharmaceutical market.

SVOLT manufacturer of electric batteries. They specialize in the manufacturing of automotive power batteries and energy storage systems. Their market applications include passenger cars, commercial vehicles, energy storage, and light power solutions. Their products include batteries and energy storage batterie. They provide users with energy vehicle charging piles, batteries recycling, and solutions.

Tongshu Gene is a high-tech enterprise that focuses on the field of tumor precision medicine. The company provides gene testing services and develops diagnostic molecular pathology projects and ctDNA precision detection systems based on high-throughput gene sequencing technology and biological information analysis to provide clinicians with consulting services including precision medication, efficacy monitoring, postoperative recurrence monitoring, and risk prediction and early detection.

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science. The company currently has more than a dozen of independently-developed mRNA drug projects, focusing on the fields of mRNA-based personalized cancer vaccines, mRNA vaccines for infectious disease, protein defects diseases, and genetic diseases, providing cure and solutions for cancer and infectious diseases, better serving patients.

Weilong Foods is a snack food brand that produces and manufactures spicy noodles, dried seafood, and other series of snack foods. The company was founded in 1999 by Liu Weiping and Liu Fuping in Luohe, Henan Province.

Hepagene Therapeutics is focused on developing innovative treatments for liver diseases. The company engages in research and development efforts aimed at addressing conditions such as non-alcoholic steatohepatitis (NASH), chronic Hepatitis B infection, and liver cancer. By concentrating on these critical areas, Hepagene Therapeutics seeks to provide effective pharmaceutical solutions that can significantly improve patient outcomes in the realm of liver health.

TechnoDerma Medicines is a private clinical-stage biopharmaceutical company dedicated to developing innovative therapies for various skin diseases. Its research and development efforts focus on small molecular drugs aimed at treating conditions such as androgenetic alopecia, atopic dermatitis, psoriasis, lupus erythematosus, and scars. The company's goal is to provide patients with safe and effective treatment options, addressing unmet medical needs in the dermatological field.

Immune-Onc Therapeutics is a newly established bio-pharmaceutical company that focuses on developing innovative therapeutic antibodies for cancer treatment. The company applies the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer patients.

Julive is a new house transaction service platform.

LakeShore Biopharma is a global, fully integrated medical company engaged in discovering, developing and commercializing innovative biotherapeutics for cancers and infectious diseases using our novel PIKA® immunomodulating technology. PIKA technology augments both innate and adaptive immune responses through the TLR3, RIG-I and MDA5 pathways. Products in clinical development include YS-ON-001 for the treatment of advanced solid tumors, YS-HBV-001 hepatitis B vaccine and the PIKA rabies vaccine for accelerated protection against rabies infection.

Teon Therapeutics is a clinical-stage biopharmaceutical company based in Redwood, California, founded in 2018. The company is focused on developing small molecule drugs aimed at cancer immunotherapy as well as addressing cardiovascular and metabolic diseases. Teon Therapeutics specializes in creating single-target small molecules that inhibit immunosuppressive and cancer-promoting signaling pathways within the tumor microenvironment. Its lead program involves an A2BR-specific antagonist, which is set to enter Phase 1b trials. By combining metabolic and GPCR immune checkpoint inhibitors, Teon aims to enhance the efficacy of immunotherapies, thereby improving long-term outcomes for cancer patients.

Clover Biopharmaceuticals is a clinical-stage biotechnology company dedicated to discovering, developing, and commercializing innovative biologic therapies primarily targeting oncology and autoimmune diseases. The company employs its proprietary Trimer-Tag technology platform to create novel biologics that focus on trimerization-dependent pathways. In addition to its therapeutic efforts, Clover is also engaged in the development of select biosimilars, utilizing its in-house cGMP biomanufacturing capabilities. The company aims to address unmet medical needs in both infectious diseases and cancer through its advanced vaccine and therapeutic candidates.

Sinovent Inc. is a biopharmaceutical company established in 2016, with its headquarters in Suzhou, China, and additional offices in Beijing and Boston. The company focuses on developing innovative treatment methods through its advanced biotechnology platform and extensive management experience. Sinovent aims to address global healthcare challenges by combining expertise in science, management, and finance. Currently, it has 12 products in development, primarily targeting oncology, autoimmune diseases, and infectious diseases.

XtalPi Inc. is a pharmaceutical technology company based in Cambridge, Massachusetts, with additional offices in China. Founded in 2014 by a team of quantum physicists from MIT, XtalPi focuses on transforming drug research and development through its Intelligent Digital Drug Discovery and Development (ID4) platform. This platform integrates quantum mechanics, artificial intelligence, and high-performance cloud computing to enhance the efficiency and accuracy of drug R&D processes. XtalPi's offerings include advanced tools for crystal structure prediction and determination, solid state testing, small molecule drug design, and AI model development. The company aims to accelerate drug discovery and development, thereby contributing to global health improvements. Its innovative technologies have garnered recognition within the industry and facilitated strategic partnerships with leading pharmaceutical companies.

Creative Biosciences is a biomedical technology company focused on developing and producing diagnostic products for tumor screening, particularly in the realm of colorectal cancer. The company specializes in fecal DNA detection technology, providing non-invasive screening kits that allow medical practitioners to accurately identify genetic abnormalities in fecal samples. These diagnostic tools are designed to aid in the early detection of intestinal cancer lesions, thereby supporting healthcare professionals and researchers in their efforts to improve cancer treatment outcomes. Through its innovative approach, Creative Biosciences aims to enhance cancer screening processes and contribute to better patient care.

Triumvira Immunologics is an immunotherapy company founded in 2015 and headquartered in Austin, Texas, with research facilities in Hamilton, Canada. The company focuses on developing innovative T cell therapies for cancer treatment, including chimeric antigen receptor (CAR) and engineered T cell receptor (TCR) therapies. Its lead product, CD19-TAC01, targets CD19 for the treatment of B cell malignancies. Triumvira's proprietary T cell Antigen Coupler (TAC) technology enhances the recruitment of the natural T cell receptor and operates independently of the major histocompatibility complex. This unique approach enables the creation of more effective therapies for a diverse range of patients suffering from both solid and liquid tumors, as well as other diseases.

Sinovent Inc. is a biopharmaceutical company established in 2016, with its headquarters in Suzhou, China, and additional offices in Beijing and Boston. The company focuses on developing innovative treatment methods through its advanced biotechnology platform and extensive management experience. Sinovent aims to address global healthcare challenges by combining expertise in science, management, and finance. Currently, it has 12 products in development, primarily targeting oncology, autoimmune diseases, and infectious diseases.

hireEZ is an AI-powered outbound recruiting platform designed to assist recruiters in proactively connecting with potential job candidates. The platform aims to empower organizations to transition from traditional inbound recruiting methods to a more strategic outbound approach, ultimately helping them achieve their hiring goals and build diverse workplaces. By providing market insights and enhancing visibility of talent, hireEZ enables recruiters to navigate the competitive talent acquisition landscape more effectively. The company's mission is to simplify the recruitment process, allowing businesses to identify and hire the right individuals to meet their workforce needs.

Enflame, also known as Suiyuan Technology, specializes in developing advanced neural network solutions for artificial intelligence applications. The company focuses on creating high-end deep learning chips designed specifically for cloud data centers, optimizing them for AI training platforms. These chips feature a proprietary architecture that delivers significant computational power while ensuring high energy efficiency and low costs. Additionally, they are programmable and compatible with mainstream machine learning frameworks, making them suitable for a wide range of AI training and optimization tasks.

Apexigen Inc. is a clinical-stage biopharmaceutical company based in San Carlos, California, dedicated to the discovery and development of antibody therapeutics for cancer treatment. The company focuses on creating innovative immuno-oncology products that leverage the patient's immune system to effectively combat and eliminate cancer. Apexigen's therapeutic pipeline includes several candidates such as APX005M and APX201 for immuno-oncology, alongside APX003 and TRK-950 for oncology, as well as APX001 for inflammation and APX003 for ocular diseases. Additionally, the company has developed the APXiMAB platform, which facilitates the discovery of antibodies targeting novel immune system components. Founded in 2010, Apexigen aims to advance next-generation therapies that address significant unmet needs in cancer treatment.

Zshield Inc. is a Beijing-based company specializing in cyberspace data security and big data business risk management. Established in 2014, it is recognized as the first high-tech firm in China to leverage big data technologies in addressing emerging information security vulnerabilities. Zshield develops advanced integrated information security solutions that utilize lightweight virtualization, deep learning, and big data analysis to provide effective monitoring of server and terminal security. Its offerings include a comprehensive information security platform and the AndunTM ZS-ISP, which supports both government and enterprise clients in navigating the complexities of modern computing environments, including cloud computing and mobile applications. As traditional security measures struggle to cope with new threats, Zshield's innovative approach aims to fortify businesses against the evolving landscape of information security challenges.

Ansun Biopharma, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, focused on developing innovative therapies to prevent and treat serious human diseases. The company specializes in host-directed anti-viral therapies, which aim to combat respiratory viral infections, including various strains of influenza and parainfluenza viruses. Its lead product candidates include Fludase, designed for the prophylaxis and treatment of respiratory infections, and Viradin, an intravenous therapeutic for sepsis and viral hemorrhagic fevers caused by pathogens such as Ebola and Marburg viruses. Additionally, Ansun Biopharma has developed TOSAP, a formulation technology for drug delivery using microspheres and nanospheres. Founded in 2003, the company was previously known as NexBio, Inc. before rebranding in 2011.

Enflame, also known as Suiyuan Technology, specializes in developing advanced neural network solutions for artificial intelligence applications. The company focuses on creating high-end deep learning chips designed specifically for cloud data centers, optimizing them for AI training platforms. These chips feature a proprietary architecture that delivers significant computational power while ensuring high energy efficiency and low costs. Additionally, they are programmable and compatible with mainstream machine learning frameworks, making them suitable for a wide range of AI training and optimization tasks.

Inspirna is a clinical-stage biopharmaceutical company focused on developing innovative drug candidates that target essential drivers of cancer. The company utilizes a microRNA-based target discovery platform to identify novel RNA dysregulated cancer drivers, which can be addressed by small molecules and biologics. Inspirna's clinical programs include first-in-class oral small molecules aimed at treating patients with RAS mutant colorectal cancer (RGX-202) and small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) (RGX-104), both currently in Phase 1b/2 trials. Through its research, Inspirna aims to provide effective treatment options that specifically target cancer metabolism and progression, offering potential advancements in cancer care.

51zhaoyou.com operates as a B2B e-commerce platform specifically tailored for the petroleum industry. It offers a comprehensive online platform that facilitates fuel trading, logistics, and financial services. The platform serves a range of customers, including prominent logistics companies in China. By providing essential information on petroleum products such as diesel oil and fuels, 51zhaoyou.com enables users to make informed decisions related to oil trading. This integration of services enhances the efficiency of transactions within the petroleum sector.

Tiger Brokers, founded in 2014, is an online brokerage firm that aims to redefine global investing through innovative technology. The company primarily targets Chinese investors and provides a comprehensive trading platform that allows users to trade equities and various financial instruments across multiple exchanges. Tiger Brokers offers a range of services, including trade order placement and execution, margin financing, account management, and investor education. The firm emphasizes delivering an excellent user experience to facilitate efficient and smart investing, while also fostering an investor community through discussions and support services.

Ansun Biopharma, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, focused on developing innovative therapies to prevent and treat serious human diseases. The company specializes in host-directed anti-viral therapies, which aim to combat respiratory viral infections, including various strains of influenza and parainfluenza viruses. Its lead product candidates include Fludase, designed for the prophylaxis and treatment of respiratory infections, and Viradin, an intravenous therapeutic for sepsis and viral hemorrhagic fevers caused by pathogens such as Ebola and Marburg viruses. Additionally, Ansun Biopharma has developed TOSAP, a formulation technology for drug delivery using microspheres and nanospheres. Founded in 2003, the company was previously known as NexBio, Inc. before rebranding in 2011.